Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Implementation of a targeted HPV educational program in a population with HIV.

Ayoub N, Sunwoo JB, Starmer HM.

World J Otorhinolaryngol Head Neck Surg. 2019 Feb 23;5(2):105-111. doi: 10.1016/j.wjorl.2018.09.006. eCollection 2019 Jun.

2.

Natural Killer Cells and Thyroid Diseases.

Lee EK, Sunwoo JB.

Endocrinol Metab (Seoul). 2019 Jun;34(2):132-137. doi: 10.3803/EnM.2019.34.2.132. Review.

3.

Corrigendum to 'Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis'. [Oral Oncol. 85 (2018) 60-67].

Chen JJ, Harris JP, Kong CS, Sunwoo JB, Divi V, Horst KC, Aasi SZ, Hollmig ST, Hara WY.

Oral Oncol. 2019 Jun 4. pii: S1368-8375(19)30171-X. doi: 10.1016/j.oraloncology.2019.05.024. [Epub ahead of print] No abstract available.

PMID:
31174982
4.

The Immune Subtypes and Landscape of Squamous Cell Carcinoma.

Li B, Cui Y, Nambiar DK, Sunwoo JB, Li R.

Clin Cancer Res. 2019 Jun 15;25(12):3528-3537. doi: 10.1158/1078-0432.CCR-18-4085. Epub 2019 Mar 4.

PMID:
30833271
5.

Organoid Modeling of the Tumor Immune Microenvironment.

Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, Liu IH, Chiou SH, Salahudeen AA, Smith AR, Deutsch BC, Liao L, Zemek AJ, Zhao F, Karlsson K, Schultz LM, Metzner TJ, Nadauld LD, Tseng YY, Alkhairy S, Oh C, Keskula P, Mendoza-Villanueva D, De La Vega FM, Kunz PL, Liao JC, Leppert JT, Sunwoo JB, Sabatti C, Boehm JS, Hahn WC, Zheng GXY, Davis MM, Kuo CJ.

Cell. 2018 Dec 13;175(7):1972-1988.e16. doi: 10.1016/j.cell.2018.11.021.

PMID:
30550791
6.

Clinical perineural invasion of cutaneous head and neck cancer: Impact of radiotherapy, imaging, and nerve growth factor receptors on symptom control and prognosis.

Chen JJ, Harris JP, Kong CS, Sunwoo JB, Divi V, Horst KC, Aasi SZ, Hollmig ST, Hara WY.

Oral Oncol. 2018 Oct;85:60-67. doi: 10.1016/j.oraloncology.2018.08.014. Epub 2018 Aug 30. Erratum in: Oral Oncol. 2019 Jun 4;:.

PMID:
30220321
7.

PD-L1 Expression and Tumor-Infiltrating Lymphocytes in High-Risk and Metastatic Cutaneous Squamous Cell Carcinoma.

Amoils M, Kim J, Lee C, Sunwoo JB, Colevas AD, Aasi SZ, Hollmig ST, Ma Y, Divi V.

Otolaryngol Head Neck Surg. 2019 Jan;160(1):93-99. doi: 10.1177/0194599818788057. Epub 2018 Jul 17.

PMID:
30012051
8.

American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults.

Orloff LA, Wiseman SM, Bernet VJ, Fahey TJ 3rd, Shaha AR, Shindo ML, Snyder SK, Stack BC Jr, Sunwoo JB, Wang MB.

Thyroid. 2018 Jul;28(7):830-841. doi: 10.1089/thy.2017.0309. Epub 2018 Jun 29.

PMID:
29848235
9.

Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma.

Tam K, Schoppy DW, Shin JH, Tay JK, Moreno-Nieves U, Mundy DC, Sunwoo JB.

Otolaryngol Head Neck Surg. 2018 Jul;159(1):76-84. doi: 10.1177/0194599818756627. Epub 2018 Feb 13.

PMID:
29436278
10.

The aryl hydrocarbon receptor modulates the function of human CD56bright NK cells.

Moreno-Nieves UY, Mundy DC, Shin JH, Tam K, Sunwoo JB.

Eur J Immunol. 2018 May;48(5):771-776. doi: 10.1002/eji.201747289. Epub 2018 Feb 12.

11.

NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma.

Brennan K, Shin JH, Tay JK, Prunello M, Gentles AJ, Sunwoo JB, Gevaert O.

Sci Rep. 2017 Dec 6;7(1):17064. doi: 10.1038/s41598-017-17298-x.

12.

CD271 Confers an Invasive and Metastatic Phenotype of Head and Neck Squamous Cell Carcinoma through the Upregulation of Slug.

Chung MK, Jung YH, Lee JK, Cho SY, Murillo-Sauca O, Uppaluri R, Shin JH, Sunwoo JB.

Clin Cancer Res. 2018 Feb 1;24(3):674-683. doi: 10.1158/1078-0432.CCR-17-0866. Epub 2017 Dec 5.

13.

Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor.

Kim J, Shin JH, Chen CH, Cruz L, Farnebo L, Yang J, Borges P, Kang G, Mochly-Rosen D, Sunwoo JB.

Oncotarget. 2017 Apr 10;8(32):52345-52356. doi: 10.18632/oncotarget.17017. eCollection 2017 Aug 8.

14.

Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.

Brennan K, Koenig JL, Gentles AJ, Sunwoo JB, Gevaert O.

EBioMedicine. 2017 Mar;17:223-236. doi: 10.1016/j.ebiom.2017.02.025. Epub 2017 Mar 1.

15.

Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy.

Makkouk A, Sundaram V, Chester C, Chang S, Colevas AD, Sunwoo JB, Maecker H, Desai M, Kohrt HE.

Ann Oncol. 2017 Feb 1;28(2):415-420. doi: 10.1093/annonc/mdw570.

16.

The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells.

Zhang LH, Shin JH, Haggadone MD, Sunwoo JB.

J Exp Med. 2016 Oct 17;213(11):2249-2257. Epub 2016 Sep 26.

17.

Flexible radioluminescence imaging for FDG-guided surgery.

King MT, Jenkins CH, Sun C, Carpenter CM, Ma X, Cheng K, Le QT, Sunwoo JB, Cheng Z, Pratx G, Xing L.

Med Phys. 2016 Oct;43(10):5298.

PMID:
27782732
18.

Transcription factor Dlx3 induces aryl hydrocarbon receptor promoter activity.

Shin JH, Haggadone MD, Sunwoo JB.

Biochem Biophys Rep. 2016 Sep;7:353-360. Epub 2016 Jun 30.

19.

ESM1 mediates NGFR-induced invasion and metastasis in murine oral squamous cell carcinoma.

Chen C, Shin JH, Eggold JT, Chung MK, Zhang LH, Lee J, Sunwoo JB.

Oncotarget. 2016 Oct 25;7(43):70738-70749. doi: 10.18632/oncotarget.12210.

20.

Development of prognostic signatures for intermediate-risk papillary thyroid cancer.

Brennan K, Holsinger C, Dosiou C, Sunwoo JB, Akatsu H, Haile R, Gevaert O.

BMC Cancer. 2016 Sep 15;16(1):736. doi: 10.1186/s12885-016-2771-6.

21.

Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.

Brooks JD, Wei W, Pollack JR, West RB, Shin JH, Sunwoo JB, Hawley SJ, Auman H, Newcomb LF, Simko J, Hurtado-Coll A, Troyer DA, Carroll PR, Gleave ME, Lin DW, Nelson PS, Thompson IM, True LD, McKenney JK, Feng Z, Fazli L.

Prostate. 2016 Nov;76(15):1409-19. doi: 10.1002/pros.23225. Epub 2016 Jun 21.

22.

Head and neck cancer immunology and immunotherapeutics: Basic concepts to clinical translational approaches.

Uppaluri R, Bell RB, Sunwoo JB.

Oral Oncol. 2016 Jul;58:49-51. doi: 10.1016/j.oraloncology.2016.05.004. Epub 2016 May 26. No abstract available.

PMID:
27238227
23.

CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1.

Lee Y, Shin JH, Longmire M, Wang H, Kohrt HE, Chang HY, Sunwoo JB.

Clin Cancer Res. 2016 Jul 15;22(14):3571-81. doi: 10.1158/1078-0432.CCR-15-2665. Epub 2016 Feb 10.

24.

Immunotherapy for Head and Neck Squamous Cell Carcinoma.

Schoppy DW, Sunwoo JB.

Hematol Oncol Clin North Am. 2015 Dec;29(6):1033-43. doi: 10.1016/j.hoc.2015.07.009. Epub 2015 Oct 20. Review.

PMID:
26568546
25.

Tumor Ulceration Does Not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults.

Keegan THM, Swetter SM, Tao L, Sunwoo JB, Clarke CA.

J Invest Dermatol. 2015 Dec;135(12):3195-3197. doi: 10.1038/jid.2015.325. Epub 2015 Aug 19. No abstract available.

26.

β-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging.

King MT, Carpenter CM, Sun C, Ma X, Le QT, Sunwoo JB, Cheng Z, Pratx G, Xing L.

J Nucl Med. 2015 Sep;56(9):1458-64. doi: 10.2967/jnumed.115.158337. Epub 2015 Jul 23.

27.

Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older men.

Kaveh AH, Seminara NM, Barnes MA, Berger AJ, Chen FW, Yao M, Johnson D, Parsa S, Quon A, Swetter SM, Sunwoo JB.

Head Neck. 2016 Apr;38 Suppl 1:E754-60. doi: 10.1002/hed.24094. Epub 2015 Jul 14.

PMID:
25914266
28.

Targeting Toll-like receptor 2 inhibits growth of head and neck squamous cell carcinoma.

Farnebo L, Shahangian A, Lee Y, Shin JH, Scheeren FA, Sunwoo JB.

Oncotarget. 2015 Apr 30;6(12):9897-907.

29.

CCR 20th anniversary commentary: Preclinical study of proteasome inhibitor bortezomib in head and neck cancer.

Allen CT, Conley B, Sunwoo JB, Van Waes C.

Clin Cancer Res. 2015 Mar 1;21(5):942-3. doi: 10.1158/1078-0432.CCR-14-2550.

30.

Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1.

Nguyen le XT, Lee Y, Urbani L, Utz PJ, Hamburger AW, Sunwoo JB, Mitchell BS.

Blood. 2015 Apr 16;125(16):2519-29. doi: 10.1182/blood-2014-12-616433. Epub 2015 Feb 17.

31.

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.

Murillo-Sauca O, Chung MK, Shin JH, Karamboulas C, Kwok S, Jung YH, Oakley R, Tysome JR, Farnebo LO, Kaplan MJ, Sirjani D, Divi V, Holsinger FC, Tomeh C, Nichols A, Le QT, Colevas AD, Kong CS, Uppaluri R, Lewis JS Jr, Ailles LE, Sunwoo JB.

Oncotarget. 2014 Aug 30;5(16):6854-66.

32.

Cancer immunosurveillance and immunoediting by natural killer cells.

Gross E, Sunwoo JB, Bui JD.

Cancer J. 2013 Nov-Dec;19(6):483-9. doi: 10.1097/PPO.0000000000000005. Review.

PMID:
24270347
33.

Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells.

Wang L, Tian WD, Xu X, Nie B, Lu J, Liu X, Zhang B, Dong Q, Sunwoo JB, Li G, Li XP.

Cancer. 2014 Feb 1;120(3):363-72. doi: 10.1002/cncr.28418. Epub 2013 Nov 4.

34.

Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor.

Shin JH, Zhang L, Murillo-Sauca O, Kim J, Kohrt HE, Bui JD, Sunwoo JB.

Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12391-6. doi: 10.1073/pnas.1302856110. Epub 2013 Jul 8.

35.

Epigenetically mediated pathogenic effects of phenanthrene on regulatory T cells.

Liu J, Zhang L, Winterroth LC, Garcia M, Weiman S, Wong JW, Sunwoo JB, Nadeau KC.

J Toxicol. 2013;2013:967029. doi: 10.1155/2013/967029. Epub 2013 Mar 7.

36.

Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence.

Ho AS, Tsao GJ, Chen FW, Shen T, Kaplan MJ, Colevas AD, Fischbein NJ, Quon A, Le QT, Pinto HA, Fee WE Jr, Sunwoo JB, Sirjani D, Hara W, Yao M.

Cancer. 2013 Apr 1;119(7):1349-56. doi: 10.1002/cncr.27892. Epub 2012 Dec 7.

37.

Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions.

Hwang I, Zhang T, Scott JM, Kim AR, Lee T, Kakarla T, Kim A, Sunwoo JB, Kim S.

Int Immunol. 2012 Dec;24(12):793-802. doi: 10.1093/intimm/dxs080. Epub 2012 Sep 7.

38.

CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma.

Janisiewicz AM, Shin JH, Murillo-Sauca O, Kwok S, Le QT, Kong C, Kaplan MJ, Sunwoo JB.

Int Forum Allergy Rhinol. 2012 Nov;2(6):465-70. doi: 10.1002/alr.21068. Epub 2012 Aug 7.

PMID:
22887934
39.

The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles.

Jang ES, Shin JH, Ren G, Park MJ, Cheng K, Chen X, Wu JC, Sunwoo JB, Cheng Z.

Biomaterials. 2012 Aug;33(22):5584-92. doi: 10.1016/j.biomaterials.2012.04.041. Epub 2012 May 8.

40.

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.

Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.

Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.

41.

Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.

Ho AS, Kaplan MJ, Fee WE Jr, Yao M, Sunwoo JB, Hwang PH.

Int Forum Allergy Rhinol. 2012 Mar-Apr;2(2):166-73. doi: 10.1002/alr.20111. Epub 2011 Dec 13.

PMID:
22170783
42.

ERK1/2 regulation of CD44 modulates oral cancer aggressiveness.

Judd NP, Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH, Lewis JS Jr, Dunn GP, Bui JD, Sunwoo JB, Uppaluri R.

Cancer Res. 2012 Jan 1;72(1):365-74. doi: 10.1158/0008-5472.CAN-11-1831. Epub 2011 Nov 15.

43.

A cisplatin-resistant subpopulation of mesenchymal-like cells in head and neck squamous cell carcinoma.

Sunwoo JB.

Cell Cycle. 2011 Sep 1;10(17):2834-5. doi: 10.4161/cc.10.17.16750. No abstract available.

PMID:
21964299
44.

Distal-less homeobox transcription factors regulate development and maturation of natural killer cells.

Sunwoo JB, Kim S, Yang L, Naik T, Higuchi DA, Rubenstein JL, Yokoyama WM.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10877-82. doi: 10.1073/pnas.0805205105. Epub 2008 Jul 29.

45.

HLA alleles determine differences in human natural killer cell responsiveness and potency.

Kim S, Sunwoo JB, Yang L, Choi T, Song YJ, French AR, Vlahiotis A, Piccirillo JF, Cella M, Colonna M, Mohanakumar T, Hsu KC, Dupont B, Yokoyama WM.

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3053-8. doi: 10.1073/pnas.0712229105. Epub 2008 Feb 19.

46.

Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinoma.

Engel SH, Hullar TE, Adkins DR, Thorstad WL, Sunwoo JB.

Laryngoscope. 2008 Mar;118(3):450-2.

PMID:
18090867
47.

Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia.

Dunn GP, Lewis JS Jr, Sunwoo JB, Uppaluri R.

Head Neck. 2008 Feb;30(2):267-72.

PMID:
17657794
48.

Mycotic pseudoaneurysm of the internal maxillary artery: case report and review of the literature.

Dunn GP, Uppaluri R, Hessler JL, Layland MK, Derdeyn CP, Sunwoo JB.

Arch Otolaryngol Head Neck Surg. 2007 Apr;133(4):402-6. Review.

PMID:
17438257
49.

Arrested natural killer cell development associated with transgene insertion into the Atf2 locus.

Kim S, Song YJ, Higuchi DA, Kang HP, Pratt JR, Yang L, Hong CM, Poursine-Laurent J, Iizuka K, French AR, Sunwoo JB, Ishii S, Reimold AM, Yokoyama WM.

Blood. 2006 Feb 1;107(3):1024-30. Epub 2005 Oct 13.

50.

Licensing of natural killer cells by host major histocompatibility complex class I molecules.

Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, French AR, Sunwoo JB, Lemieux S, Hansen TH, Yokoyama WM.

Nature. 2005 Aug 4;436(7051):709-13.

Supplemental Content

Loading ...
Support Center